Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,628 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02626455 | Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)(CHRONOS-4) | terminated | Phase 3 | 551 | BayerINDUSTRY | 35 | Dec 11, 2024 | clinicaltrials |
| NCT04338685 | A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases | completed | Phase 1 | 55 | Hoffmann-La RocheINDUSTRY |
| 6 |
| Dec 9, 2024 |
| clinicaltrials |
| NCT04917484 | Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients(DOBATOC) | recruiting | Phase 2 | 100 | Tine Gregersen, MDOTHER | 1 | Dec 9, 2024 | clinicaltrials |
| NCT01288911 | A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer | completed | Phase 2 | 375 | Astellas Pharma IncINDUSTRY | 8 | Dec 6, 2024 | clinicaltrials |
| NCT04565769 | Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors | active not recruiting | — | 100 | Aarhus University HospitalOTHER | 1 | Dec 6, 2024 | clinicaltrials |
| NCT04798898 | Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation(ISCOLIM) | recruiting | N/A | 200 | University of AarhusOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT06007027 | Vaginal CO2 Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors | recruiting | N/A | 60 | University of AarhusOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT04533217 | Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma. | recruiting | N/A | 90 | Spine Centre of Southern DenmarkOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT05153954 | Quantitative ICG Fluorescence Angiography in Colorectal Surgery(QUANTICO) | completed | — | 114 | Zealand University HospitalOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT06306274 | Topical Tacrolimus for Breast Cancer-related Lymphedema | enrolling by invitation | Phase 2 / Phase 3 | 80 | Odense University HospitalOTHER | 1 | Dec 2, 2024 | clinicaltrials |
| NCT05372536 | Home Chemotherapy Intervention for Children With Cancer - a Feasibility Study(INTACTatHome) | completed | N/A | 15 | Rigshospitalet, DenmarkOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT02927262 | A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission | completed | Phase 2 | 98 | Astellas Pharma Global Development, Inc.INDUSTRY | 21 | Nov 26, 2024 | clinicaltrials |
| NCT06306599 | Human-AI Collaboration for Ultrasound Diagnosis of Thyroid Nodules - a Clinical Trial | completed | N/A | 20 | Rigshospitalet, DenmarkOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT02926053 | TIL Therapy for Metastatic Renal Cell Carcinoma | completed | Phase 1 | 5 | Inge Marie SvaneOTHER | 1 | Nov 22, 2024 | clinicaltrials |
| NCT04741945 | Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS | recruiting | Phase 2 | 40 | Kirsten GrønbækOTHER | 1 | Nov 22, 2024 | clinicaltrials |
| NCT02919787 | Nordic Pancreatic Cancer Trial (NorPACT) - 1 | active not recruiting | Phase 2 / Phase 3 | 140 | Oslo University HospitalOTHER | 4 | Nov 20, 2024 | clinicaltrials |
| NCT02181413 | A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant | completed | Phase 3 | 656 | TakedaINDUSTRY | 33 | Nov 19, 2024 | clinicaltrials |
| NCT05760755 | Stick Together - Pilot Intervention Study | completed | N/A | 44 | Rigshospitalet, DenmarkOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT06222957 | The Effects of HER2 Receptor Signaling on Human Brown Fat Activity(HEAT) | recruiting | — | 30 | Rigshospitalet, DenmarkOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT01723280 | Supplemental Oxygen - Effect on Occurrence of Subsequent Cancer After Abdominal Surgery (Follow-up of the PROXI Trial)(PROXI) | completed | — | 1,386 | Lars S. RasmussenOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT05826158 | 18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma | recruiting | N/A | 25 | Rigshospitalet, DenmarkOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT06689332 | Improving Quality of Life in Frail, Older Patients with Hematological Cancer Through Geriatric Assessment and Treatment - a Pilot Study(IMPROVE pilot) | completed | N/A | 17 | Odense University HospitalOTHER | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06684795 | FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery | unknown | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06685562 | The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology | recruiting | — | 500 | Leiden University Medical CenterOTHER | 3 | Nov 12, 2024 | clinicaltrials |
| NCT01318642 | Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas | terminated | Phase 2 | 10 | NantBioScience, Inc.INDUSTRY | 13 | Nov 8, 2024 | clinicaltrials |
| NCT05394350 | A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002) | terminated | Phase 1 / Phase 2 | 27 | Merck Sharp & Dohme LLCINDUSTRY | 5 | Nov 8, 2024 | clinicaltrials |
| NCT03215511 | A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer | completed | Phase 1 | 81 | BayerINDUSTRY | 10 | Oct 30, 2024 | clinicaltrials |
| NCT03296137 | Adoptive Cell Therapy Across Cancer Diagnoses | completed | Phase 1 / Phase 2 | 25 | Inge Marie SvaneOTHER | 1 | Oct 26, 2024 | clinicaltrials |
| NCT04358458 | First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas | terminated | Phase 1 / Phase 2 | 46 | GenmabINDUSTRY | 5 | Oct 24, 2024 | clinicaltrials |
| NCT03126591 | A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 1 | 41 | Eli Lilly and CompanyINDUSTRY | 4 | Oct 23, 2024 | clinicaltrials |
| NCT03191786 | A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy(IPSOS) | completed | Phase 3 | 453 | Hoffmann-La RocheINDUSTRY | 24 | Oct 23, 2024 | clinicaltrials |
| NCT02495974 | European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)(PREMISE) | completed | — | 1,763 | Astellas Pharma Europe Ltd.INDUSTRY | 16 | Oct 21, 2024 | clinicaltrials |
| NCT03240523 | A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids(ASTEROID 5) | terminated | Phase 3 | 766 | BayerINDUSTRY | 23 | Oct 18, 2024 | clinicaltrials |
| NCT03238053 | Laser Treatment of Genito-urinary Syndrome in Women | withdrawn | N/A | 0 | Herning HospitalOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT04758988 | AI Augmented Training for Skin Specialists(AISC-SS) | completed | N/A | 1,500 | Herlev HospitalOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT05655715 | Checkpoint Inhibitors and SBRT for MCRPC(CheckPRO) | completed | Phase 2 | 90 | Herlev and Gentofte HospitalOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT02516813 | Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy | completed | Phase 1 | 52 | EMD Serono Research & Development Institute, Inc.INDUSTRY | 8 | Oct 15, 2024 | clinicaltrials |
| NCT03164993 | Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer(ALICE) | completed | Phase 2 | 68 | Oslo University HospitalOTHER | 2 | Oct 15, 2024 | clinicaltrials |
| NCT03189719 | First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590) | completed | Phase 3 | 749 | Merck Sharp & Dohme LLCINDUSTRY | 26 | Oct 15, 2024 | clinicaltrials |
| NCT05706740 | Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life(SERENITY) | completed | — | 467 | Johannes Gutenberg University MainzOTHER | 8 | Oct 15, 2024 | clinicaltrials |
| NCT04428333 | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma(INDUCE-4) | terminated | Phase 3 | 117 | GlaxoSmithKlineINDUSTRY | 19 | Oct 9, 2024 | clinicaltrials |
| NCT05982600 | Safety and Avoidance of Futile Excisions Through Skin Tele-triage(SAFEST) | completed | — | 5 | Herlev HospitalOTHER | 1 | Oct 8, 2024 | clinicaltrials |
| NCT06627634 | Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver(LEVECA) | recruiting | N/A | 20 | Aarhus University HospitalOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT02601937 | EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma | completed | Phase 1 | 109 | Epizyme, Inc.INDUSTRY | 9 | Oct 3, 2024 | clinicaltrials |
| NCT03656731 | Exercise in Older Women With Breast Cancer During Systemic Therapy | completed | N/A | 68 | Herlev and Gentofte HospitalOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT05196334 | Pharmacotyping of Pancreatic Patient-derived Organoids | recruiting | — | 88 | Herlev HospitalOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT05696314 | Surgeon-performed Outpatient Transoral and Transcervical Ultrasound of the Oropharynx(SPOT-US) | completed | N/A | 201 | Rigshospitalet, DenmarkOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT06623903 | Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy(EMETA) | not yet recruiting | — | 112 | Aarhus University HospitalOTHER | 1 | Oct 2, 2024 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials